Biotech China 2014

Surgery: Joslin Diabetes Center

Total Score People Score Events Score
9 5 4
Date Event Presentation Speakers
January 12, 2011 Type 2 Diabetes, Insulin Resistance and Metabolic Dysfunction (J1) Insulin Resistance, Mitochondrial Dysfunction and Lipotoxicity in Humans | New and Novel Aspects of Insulin Signaling and Insulin Resistance C. Ronald Kahn
Panel: Mechanisms of Insulin Resistance: Recent Advances and Current Controversies (Joint) | Columbine Ballroom Laurie J. Goodyear
Insulin Signaling, Action and Secretion | Exercise-Induced Enhancement of Insulin Action Laurie J. Goodyear
Developmental Origins of Obesity and Type 2 Diabetes | Columbine Ballroom Mary Elizabeth Patti
January 12, 2011 Obesity (J2) Diabetes (J1) | New and Novel Aspects of Insulin Signaling and Insulin Resistance C. Ronald Kahn
Diabetes (J1) | Exercise-Induced Enhancement of Insulin Action Laurie J. Goodyear
Developmental Origins of Obesity and Type 2 Diabetes | Columbine Ballroom Mary-Elizabeth Patti
In Search of Targets for Restoring beta-cell Function | Columbine Ballroom Laurie J. Goodyear
October 20, 2010 2010 Cardiometabolic Health Congress Dinner Symposia - Diabetes, Dyslipidemia, and Hypertension: Identifying the Connections and Seizing the Opportunities for Global Cardiometabolic Risk Reduction Om P Ganda
September 26, 2007 Cardiometabolic Health Congress 2007 Breakfast Symposium | Cardiometabolic Risk Reduction: Novel Strategies for Achieving Lipid and Glycemic Targets Om P Ganda
The Science Behind Insulin Resistance and Its Impact on Cardiometabolic Risk C. Ronald Kahn
Diabetes Prevention: Does It Work? Is It Worthwhile? C. Ronald Kahn
4th Annual Pharma R&D Asia Congress
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.